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Serial study of circulating immune complexes before and after
renal transplantation. To clarify the relationship of circulating
immune complexes (CIC) to acute rejection or intercurrent infec-
tion, we studied the presence of CIC's by four methods in renal
allograft recipients, by serial monitoring, before and after trans-
plantation, of both dC and donor-specific immunologic parame-
ters. Three of the methods were dependent on the precipitation
of CIC with low concentrations of polyethylene glycol (PEG).
They were the radioisotopic conglutinin-binding assay, the Clq-
binding assay, and the radial immunodiffusion (RID) of IgG and
1gM in PEG precipitates. The fourth method was the Raji cell
assay. These techniques were applied to sequentially collected
serum samples from 26 patients, both before and up to 20 months
after transplantation (mean followup, 7.2 months). CIC's were
present in 14 out of 26 (54%) patients studied before trans-
plantation. Glomerulonephritis was the primary renal disease in
only half of these 26 patients. Of this half, 12 (86%) were positive
after transplantation, whereas only 2 of the 12 (17%) with no CIC
before transplantation became positive subsequently. CIC's were
demonstrable in 19 out of 28 patients (68%) during the post-
transplant observation. In five instances (4 patients), they ap-
peared only transiently (in 1 in association with rejection and in
another 2 with intercurrent infection). Tn 14 patients, CIC's were
detectable until the end of the observation period. In 23 rejection
episodes in 16 renal allograft recipients, CIC's were present in
association with 9(39%) of these episodes, but the appearance or
reappearance of CIC's coincided with rejection in only 5 of these
episodes (or 22%). Thus, a cause-and-effect relationship is not
established. In contrast, tests for donor-specific immunologic
monitoring, especially lymphocyte-mediated cytoxicity (LMC-
D), became positive for 63% of the rejections and became nega-
tive when rejection activity subsided. CIC's were present at the
time of only 4 of 15 infective episodes (27%). The fate of the
allograft was no different in the CIC-positive group compared
with those in whom they could not be detected. Among another
33 patients with long-surviving grafts (mean, 3.7 years) and stud-
ied for brief periods, CIC's were detected in 6 (18%). All 6 had
excellent graft function though 1 had developed membranous
glomerulonephritis.
Étude séquentielle des inununs complexes circulants avant et
après transplantation rénale. Les immuns complexes circulants
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(CIC) ont été étudiés par quatre méthodes chez des receveurs de
greffe rénale de facon séquentielle avant et après trans-
plantation. Les paramétres immunologiques spécifiques des don-
neurs ont été évalués. Le but était d'étudier la relation even-
tuelle de CIC et du rejet aigu ou de l'infection intercurrente. Les
trois mCthodes utilisant Ic polyéthylène glycol (PEG) Ctaient la
liaison aux conglutinines, la liaison au Clq et l'immunodiffusion
radiale (RID) de l'IgG et de l'IgM dans des précipitats par PEG.
La quatriCme était le test de Raji. Ces techniques ont été appli-
quées au serum obtenu séquentiellement de 26 malades, avant et
jusqu'à 20 mois après la transplantation (durée moyenne de sur-
veillance, 7,2 mois). Les CIC ont été observes chez 54% (14/26)
des malades étudiés avant Ia transplantation. La moitié seule-
ment de ces malades étaient atteints de glomérulonéphntes.
Douze (86%) parmi ces malades ont Cté positifs aprCs trans-
plantation alors que seulement 2 parmi les 12 (17%) qui n'avaient
pas de CIC avant Ia transplantation sont devenus positifs. Les
CIC ont etC mis en evidence chez 19/28 malades (68%) au cours
de la pCriode de surveillance après Ia transplantation. Dans 5 cas
(4 malades), ils sont apparus transitoirement (dans 1 cas en asso-
ciation avec un rejet et dans 2 cas avec une infection inter-
currente). Chez 14 malades les CIC ont Cté dCtectCs tout au long
de Ia pCriode d'observation. Dans 23 episodes de rejet de 16
greffes rénales les CIC ont été observes 9 fois (39%) mais
l'apparition ou Ia réapparition des CIC n'a coIncide avec Ic rejet
que dans 5 de ces cas (22%). Ainsi une relation de cause a effet
n'est pas établie. Au contraire, les tests tels que la cytotoxicitC a
mediation lymphocytaire (LMS-D) sont devenus positifs dans
63% des rejets puis se sont nCgativCs quand l'activité de rejet
s'est éteinte. Les CIC n'ont Cté observes que quatre fois au
cours de quinze episodes infectieux (27%). Le devenir de Ia
greffe n'a pas été different dans le groupe ayant des CIC par
comparaison avec le groupe dans lequel ils n'ont pas été dé-
tectés. Parmi 33 malades dont les greffes fonctionnaient depuis
longtemps (3,7 ans en moyenne), et qui ont Cté Ctudiés pendant
des temps brefs, des CIC ont été observes chez 6(18%). Tous les
6 avaient une greffe fonctionnant parfaitement bien que sur
l'une d'elle une glomérulonéphrite extra-membraneuse soit ap-
panic.
Humorally mediated tissue injury to the renal al-
lograft has been observed in as many as two thirds
of transplant recipients [1, 2]. Both immuno-
fluorescent and electron microscopic studies that
use ferritin-labeled antibodies to immunoglobulins
and complement have supported this finding [3].
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Further, electron microscopy has demonstrated the
presence of electron-dense deposits in the glomeruli
at mesangial, subendothelial, epimembranous, and
subepithelial locations [4, 5].
In addition to the direct interaction that occurs be-
tween antibodies and graft antigens in situ, tissue
deposition of circulatory immune complexes (CIC)
provides another plausible explanation for the local-
ization of immunoglobulins in the graft.
In rat, after renal allograft transplantation, gb-
merular deposition of immunoglobulins has been
seen in the recipient's original kidney, presumably
evidence for CIC-mediated glomerular injury [6].
Glomerulonephritis affecting a patient's own kid-
neys due to the deposition of histocompatible anti-
gen-antibody complexes has also been reported to
occur in human renal transplant rejection [7]. More
recently, CIC deposition has been implicated as a
mediator of humoral rejection in human renal allo-
grafts: its appearance even preceded clinical rejec-
tion [8], and it was not found in association with
cell-mediated acute rejections. Such close associa-
tion between CIC's and acute rejections, however,
was not observed by others [9, 10]. Some have pos-
tulated that transient mixed cryoglobulinemia, pre-
sumably of immune complex nature, may occur
with intercurrent infections [11], and these cryo-
globulins would also be detected as CIC's.
Very few studies of renal transplantation have in-
cluded both serial monitoring for CIC's before and
after grafting and donor-specific immunologic mon-
itoring after transplantation. In this paper, we re-
port serial observations in 26 patients from before
to as long as 20 months after transplantation in
whom both types of monitoring data are available
for comparison. Two other patients were monitored
sequentially after they underwent transplantation,
but pretransplant serum samples were lacking. An-
other 33 patients, with long-term surviving grafts,
have been monitored for just a part of their post-
transplant course.
Four methods were used, each of which detects
CIC's by different properties of the complex. The
simultaneous use of several techniques permits in-
ference as to certain dC qualities, such as antibody
class and complement-fixing and complement-acti-
vating characteristics.
Methods
GIG assays. Four methods were used. Three
were based on the precipitation of CIC's with low
concentrations of polyethylene glycol (PEG) and
subsequent CIC quantitation with (a) radioisotopic
labeled bovine conglutinin (K), (b) Clq binding, or
(c) direct IgG and 1gM measurement by radial im-
munodiffusion (RID). The fourth method involved
binding of dC' s to cultured Raji cells with sub-
sequent use of radioisotopic iodine-labeled anti-
human IgG as the marker.
The radioisotopic conglutinin binding assay (RK-
BA) was performed as described in Ref. 12: Radio-
isotopic conglutinin fixes to C3d-bound immune
complexes in the fluid phase, which is then precipi-
tated by PEG. This restricts its specificity to CIC's,
which activate complement by the classical or the
alternate pathway. Antibodies to bovine serum pro-
teins in human serum are one potential source of
false-negative results in this assay.
The Clq-binding assay (Clq-BA) was done by the
method of Zubler and Lambert [13] with some mod-
ifications. Three percent PEG with 1% bovine
serum albumin (BSA) was used. The BSA prevents
nonspecific precipitation of Clq. The assay detects
Clq-fixing immune complexes (classical pathway
only). Antibody to bovine serum albumin in human
serum might form complexes with BSA. This possi-
bility was not believed to be at all likely but cannot
be excluded if our Clq assay were used alone.
IgG and 1gM in the PEG precipitate was quan-
titated by radial immunodiffusion with the Mancini
technique [14]. Precipitation was carried out at a fi-
nal PEG concentration of 3.5% in 0.1 M borate-buf-
fered saline solution that contains 0.06 M EDTA at a
final serum dilution of 1/20. The method quantitates
immune complexes by their immunoglobulin (Ig)
content irrespective of their complement-activating
properties.
The normal ranges and standard deviations for
each technique were calculated from measurements
of normal human serum (Table 1). The percent
binding of radiolabeled RK or Clq was derived from
the amount of a standard quantity of radiolabeled
RK or Clq precipitated by PEG expressed as a per-
centage of the amount of that standard precipitated
by the addition of 20% trichloracetic acid (TCA).
Test results above 2 SD'S of the mean were con-
sidered to be positive (+), and the results between
1 and 2 SD's of the mean as doubtful (?).
Raji cell assay. Raji cell assay was performed as
originally described by Theofilopoubos and Dixon
[15] except that 8 to 10 normal serum samples were
included with each run, and the mean and SD of this
group were determined. Any value above 2 SD'S
above the means of these normal samples was con-
sidered to be positive, and the degree of positivity is
expressed in SD units. Raji cells bear receptors for
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I SD Mean + 2 SD
(+)
RK-bindingassay,%BA 49 3.0 2.9 5.9 8.8
Clq-binding assay, % BA 30 6.0 2.6 8.6 11.2
Radial immunodiffusion
IgG,mgldl 60 0.3 0.6 0.9 1.5
IgM,mg/dl 60 1.1 2.1 3.2 5.3
a The question mark in parentheses (?) denotes that the results for positivity of dC are doubtful. The plus sign in parentheses (+)
denotes that the presence for CIC is considered to be positive. See Methods.
C3b and C3d in addition to Clq and Fc, but they
principally detect CIC's with bound activated C3b
products [16].
These four methods were examined previously in
a double-blind study of normal and pathologic
serum samples and were found to be significantly
correlated [12].
Serum collection. All posttransplant blood sam-
ples were left to coagulate at room temperature for
2 to 3 hours, low-density lipoproteins were removed
by centrifugation at x30,000g for 10 mm, and serum
aliquots were stored at —70° C. Each sample was
thawed only once for the assays. Some pre-
transplant serum samples were thawed more than
once, but a limited study on positive and negative
transplant serum samples in which "once-thawed'
and "several-times-thawed" samples were com-
pared failed to show significant differences in the
four CIC assays. None of the serum was treated
with heat prior to assay.
Immunologic monitoring. Patients were serially
monitored for donor-specific complement-depen-
dent cytotoxicity (CDC-D) and lymphocyte-mediat-
ed cytotoxicity (LMC-D), both in crossmatch tests
prior to transplantation and then sequentially, after
grafting by using techniques established in our labo-
ratory [17].
Patients studied. Twenty-six patients were stud-
ied serially before and after renal transplantation
(group 1). Renal failure was attributed to glomerulo-
nephritis in 15 and to end-stage pyelonephritis in 9
(4 of whom probably had no calyceal deformity or
interstitial nephritis), to polycystic disease in I, and
to diabetic nephropathy in 1. All patients had been
maintained on intermittent hemodialysis for varying
periods (3 months to 9 years) prior to trans-
plantation. Two to four serum samples (mean, 2.8)
collected during 0 to 6 months prior to surgery were
studied by RK-binding, Clq assay, and Ig quan-
titation, and, on at least one sample, by Raji cell
assay.
All pretransplant CDC crossmatch tests were
negative, as were 24 of 26 LMC crossmatches in
this group.
The posttransplant observation period ranged
from 1 to 20 months (mean, 7.2 months) during
which 4 to 18 serum samples (mean, 9.2) per patient
were examined by the three PEG methods and 1 to
5 samples by the Raji cell test. The first post-
transplant serum sample was obtained less than a
week after transplant in 15 patients, in the 2nd week
in 7 patients, and between the 5th and 21st weeks in
the other 6.
Twenty-three rejection episodes were studied in
16 of the patients in this group. These rejections
were treated with methyl prednisolone sodium suc-
cinate (SoluMedrol®), 1 g i.v., for 3 or 4 days. Re-
jection was diagnosed by clinical criteria: a sus-
tained rise of 25% in serum creatinine (minor) or a
rise >50% in serum creatinine (major) where other
factors such as obstruction or infection were ex-
cluded clinically; and by hyperchloremic acidosis.
Donor-specific immunologic in vitro tests were
done more frequently at these times but were not
used as criteria for rejection.
Clinical infections (baeterial, viral, and pro-
tozoal) occurred in 13 patients in group 1 (15 epi-
sodes) during the observation period: urinary tract
infections in 5, wound infections in 2, throat and
chest infections in 5, and infection at other sites in
3. None of the patients were hepatitis B surface an-
tigen positive. One patient developed breast cancer
6 months after transplantation. No patient received
antilymphocyte globulin.
In a second group of 33 patients with graft surviv-
al of ito 10 years (mean, 3.7 yr), studies were done
on 2 to 9 serum samples per patient (mean, 3.6 sam-
ples) by all three PEG methods. The period of ob-
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servation ranged from 2 weeks to 14 months (mean,
6.2 months per patient). Raji cell assays were not
performed in this group of patients.
Renal histology. Histologic observations on the
transplanted kidneys were made in 6 patients in
group 1 and in 3 in group 2 by light, electron, and
fluorescence microscopy.
Statistics. Overall correlation between the four
methods for detection of CIC's in pre- and post-
transplant serum samples was examined by Pear-
son's coefficient of correlation.
Results
UC's before transplantation. CIC's were detect-
ed in 14 of 26 patients (54%) before transplantation.
All four methods (the radial immunodiffusion quan-
titations of IgG and 1gM after PEG precipitation
being one method) were positive in 4, three meth-
ods in 6, two methods in 2, and the Raji cell test
alone in 2 (Fig. 1, even though the Raji test was not
done on 6 of the serum samples in this figure). Two
of these patients were strongly positive, one of
whom had received many blood transfusions during
Fig. 1. The frequency of circulating i,nmune complexes (C'IC)
detected by different methods in 26 patients before undergoing
renal transplantation. Twenty patients were studied by the Raji
technique. Shaded areas indicate mean 1 SD to 2 SD in normal
persons for each method. The polyethylene glycol (PEG) tests
and the Raji assay were all done on the same pretransplant serum
samples for these 20 patients. For the remaining 6 patients, the
results plotted refer to the serum closest to the transplant date.
PEG precipitation of radioisotopic conglutinin and Clq is ex-
pressed as a percent of radioisotopic label bound by precipitation
with 20% TCA.
the dialysis period with consequent wide-spectrum
humoral presensitization to a lymphocyte panel in
CDC testing. Primary renal disease in 7 of these 14
patients (50%) was membranoproliferative glomeru-
lonephritis in 5 and end-stage glomerulonephritis in
2. Of the remaining 7, 6 had chronic pyelonephritis
(though in 3 of these there was no calyceal defor-
mity to suggest interstitial nephritis), and I had dia-
betic nephropathy. Both CIC-positive and -negative
subgroups of patients had been on prolonged main-
tenance hemodialysis (mean, 18.8 months) for com-
parable periods of time.
CIC's after transplantation. CIC's were demon-
strable in 19 of the 28 patients (68%) during post-
transplant observation. In five instances (4 pa-
tients), CIC appeared transiently (demonstrable in 1
or 2 serum samples only). In 15 patients, the pres-
ence of CIC's persisted for many months—in 14 of
these it persisted until the end of the observation
period, and in the remaining patient it disappeared
after 16 weeks. The time of first appearance of
CIC's also varied, to immediately after trans-
plantation in some but at variably later times in oth-
ers.
Relation between ('IC's before and after trans-
plantation. Of the 14 patients with CIC's before
transplant, 12 (86%) also had them following trans-
plantation, but CIC's persisted into the immediate
posttransplant period in only 2 of 7 (in whom there
were adequate samples). In the remaining 5 of this
subgroup of 7, CIC's disappeared after trans-
plantation only to reappear at varying intervals (4 to
11 weeks). Five other patients, positive both before
and after transplantation, had too few serum sam-
ples to plot the immediate posttransplant course.
Only in 2 of 12 patients (17%) without pre-
transplant CIC's did they appear de novo following
transplantation.
dC associations with clinical events. In five in-
stances there was transient appearance of CIC after
transplantation: 1 could be associated with acute
graft rejection, 2 more with infections (urinary in-
fection or purulent chest infection), but the remain-
ing 2 could not be associated with a clinical event.
Among 15 patients with posttransplant CIC's for
prolonged periods, 12 (86%) had had CIC's in the
pretranspiant period.
The results for one patient in whom CIC's ap-
peared for the first time after transplantation, and
persisted for 3 months, are shown in Fig. 2. He had
a bacterial wound infection associated with rejec-
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Fig. 2. Sequential monitoring of circulating immune complexes(GIG) in a patient whose original kidney disease was chronic py-
elonephritis and whose pretranspiant serum sample showed no
CIC's. CIC levels rose (positive by three methods) about the
time of a "major" rejection episode, which followed closely on a
postoperative infection of the throat (herpes simplex virus). The
CIC persisted for nearly 3 months. His serum creatinine was 1.6
mg/dl at 21 weeks.
the episode, and shortly after this three CIC assays
showed a marked rise. But, this type of response is
exceptional and is not typical of rejection and infec-
tion episodes in these patients as a group.
Figure 3 illustrates the results from a patient in
whom reappearance of CIC's in the posttransplant
period was not associated with any untoward clini-
cal event, infective, or rejection. This was similar to
7 of the 12 patients with CIC's before and after
—10 —5 0 5 10 15
Time, weeks
Fig. 3. Patient with diabetes mellitus requiring insulin. In the
immediate posttransplant period, circulating immune complexes
(detected by Clq binding assay and Raji technique performed pri-
or to transplant) disappeared, but recurred by the 12th week in
these same two techniques. Conglutinin binding was negative
throughout. There were no episodes of graft rejection or compli-
cating infections. Graft function was excellent (serum creatinine,
1.1 mg/dl) and donor-specific immunologic monitoring was nega-
tive throughout.
grafting. In 3 patients, acute rejections occurred in
10 association with the appearance of CIC's.Figure 4 illustrates the course of a patient who
8 had a severe surgical wound infection during which
period CIC levels, as detected only by RK-BA,
6 were high; they later subsided.
In another patient, as seen in Fig. 5, CIC's did not
appear with a prolonged rejection period (when
LMC-D was positive) but did become positive by
2 Raji and Clq assays at a time when breast cancer
was detected clinically.
Graft rejections and CIC. Twenty-three graft re-jection episodes were observed in 16 patients in-
cluded in group 1. Nine of these rejections were
clinically "minor," 10 were "major but revers-
ible," and 3 were irreversible. One rejection was
the slow progressive type. CIC's were detected
with 9 episodes of rejection (39%) and were demon-
strable before, during, or after the rejection epi-
sode. The appearance or reappearance of CIC's
could be said to have coincided with rejection in on-
ly 5 of them (22%). Thus, the presence of CIC is not
established as having a cause-and-effect relation-
ship to acute rejection. In the other 14 rejection epi-
sodes (6 1%), 2 of them irreversible, CIC's were not
detected. The appearance of CIC's when associated
with rejections was not correlated to clinical assess-
ment of severity of rejection.
—10 —5 0 5 10 15 20 25
Time, weeks
Fig. 4. Circulating immune complexes (GIG) and major clinical
events in a patient who originally had had membranoprolfera-
tive glomerulonephritis (type I). Before transplantation, CIC's
were positive by Raji and conglutinin techniques. Severe surgical
wound infection was associated with the return of CIC's to high
levels (as detected only by conglutinin technique). Transplant
biopsy at 20 weeks showed mesangial and paramesangial elec-
tron-dense deposits. Graft function was only moderate (creati-
nine, 2.5 mg/dl) due to partial infarction of graft, but remained
stable. No rejections were diagnosed and immunologic mon-
itoring by complement-dependent cytotoxicity and lymphocyte-



























Immune complexes in renal transplantation 337
Immunologic monitoring and acute rejections.
Assays of donor-specific lymphocyte-mediated
cytotoxicity (LMC) or complement-dependent hu-
moral cytotoxicity (CDC) were performed at regu-
lar intervals in all patients where donor lympho-
cytes were adequately cryopreserved for later test-
ing. They were available for 19 of these 23 episodes
of rejection. LMC-D became positive with 12 rejec-
tions (63%) and CDC-D also became positive in 1 of
these (5%). Donor-specific immunologic monitoring
became positive in about two thirds of the rejec-
tions and averted to negative after the wave of re-
jection activity had passed, an incidence com-
parable with that previously reported [17].
Transplant histology. Histologic examination
was performed on five rejected transplant kidneys.
In the two kidneys where CIC's had been present in
the patient's serum, there were no electron-dense
deposits, fibrin, or Ig in the glomeruli. in the other
three kidneys where CIC's had been absent from
the patient's serum, again no immune deposits or
fibnn were detected in the glomeruli.
In a sixth kidney where CIC's had persisted in the
patient's serum but no episodes of clinical rejection
had occurred, a renal biopsy was performed be-
cause of proteinuria of more than 3 glday. In this
biopsy, electron-dense deposits were present in the
mesangium and paramesangium. This patient had
had membranoproliferative glomerulonephritis pri-
or to transplantation, and it is believed that protein-
uria was due to recurrence of original disease.
Intercurrent infections. During the posttransplant
observation, 13 patients had 15 episodes of infec-
tion. These included viral (cytomegalovirus [CMV]
and herpes simplex, as diagnosed by rising serum
titers during subsequent weeks), bacterial (pneu-
mococcal, staphylococcal, Escherichia coli), and
protozoal (Pneumocystis carinii) infections. The re-
lationship between CIC and infection was, however,
evident only in 4 episodes. In 2 of these, CIC ap-
peared transiently during urinary infection with E.
coli and a purulent chest infection. In the 3rd, the
patient had CMV pneumonitis, followed by per-
sistently elevated antibody titers, and persistent
dC. In the 4th, a severe wound infection compli-
cated the postoperative period, and was followed
by persistent IC's in the serum of the patient.
CIC's and graft function. Graft outcome in those
patients with persistent CIC's did not differ from
those without. Of 15 patients with persistent CIC's,
10 (67%) had either excellent or good graft function
(serum creatinine < 2.4 mg!dl) compared with 9 of
13 (69%) patients without CIC's.
CIC's in patients with prolonged graft survival
(group 2). Of the 33 patients included in group 2 (all
with long graft survival), 6 had circulating immune
complexes (18%). All 6 patients had excellent graft
function. As a group they did not differ from the
rest. One female patient with CIC's developed
membranous glomerulonephritis in the transplanted
kidney (her original disease had been crescentic gb-
merulonephritis). One patient with recurrent dense-
deposit disease and another with tubulointerstitial
immune complex disease had no detectable dId.
Correlations between methods. Correlations be-
tween CIC methods were obtained from analysis of
all serum samples on which all four methods were
done (84 samples; 74 from 26 patients studied serial-
ly, 10 from 6 other transplant recipients). Correla-
tion coefficients (r) were: Clq-BA/RK-BA = 0.42 (P
= 0.001); Clq-BA/Raji = 0.03 (P = 0.4); RK-BA/
Raji = 0.21 (P 0.028) for the principal combina-
tions. The relatively low correlation coefficients are
not unexpected. CIC methods differ widely in the
physicochemical nature of their binding to com-
plexes, and it is this diversity that justifies a "plural-
ity of methods" approach. Two other correlation
coefficients, for RID-IgM/Clq-BA and RID-IgM/
RK-BA, were considerably higher, 0.76 and 0.61,
respectively. This may mean that noncomplexed
1gM was nonspecifically precipitated with CIC's in
these serum samples. Also, noncomplexed 1gM
may have been present in increased concentration
in these samples (and would then be more readily
PEG precipitated), but this quantitation was not
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Fig. 5. Patient who had suffered from chronic pyclonephritis
leading to uremia and hemodialysis. Pretranspiant circulating
immune complexes (CIC) were detected by the Clq binding as-
say. After transplantation, there was a transient rise to border-
line positivity in the Clq binding assay (just 2 so above mean for
normal values) during the early stage of a major" rejection
(confirmed by positivity in lymphocyte-mediated cytotoxicity).
At the 30th posttransplant week, CIC's reappeared (detected by
the Raji test and, later, by the Clq binding assay). Breast malig-
nancy was diagnosed about the same time.
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Discussion
The transplanted kidney should provide, theoreti-
cally, a favorable milieu for the formation of circu-
lating immune complexes (CIC) because of contin-
ued presence of foreign antigens, repeated immuno-
logic damage to the graft from rejections, reduced
reticuloendothelial function [18], frequent inter-
current infections, and prior immunologic disease
such as glomerulonephritis. Immune complexes so
formed might have varying characteristics due to
antigenic diversity and class of antibody response.
Because most CIC methods are selective in nature,
simultaneous application of several methods should
not only increase overall sensitivity but also de-
crease false-positive results from substances which
interfere with individual assays.
Previous studies on CIC's following trans-
plantation have been largely restricted to single
methods applied to single serum samples per pa-
tient. In particular, the CIC status of these patients
before transplantation and its role subsequently
have not been examined closely, and the relation-
ship between serial monitoring of CIC and donor-
specific immunologic tests has not been established.
The present study uses four methods that have
been applied to multiple serial serum samples. It
shows that CIC's are frequently demonstrable be-
fore (54%) and after (68%) transplantation. Similar
results have been reported also by other workers
[10, 19]. Primary renal disease alone does not ac-
count for CIC's in our pretransplant patients be-
cause CIC's are also detected in patients with dis-
ease of supposedly nonimmunologic pathogenesis.
Repeated hemodialysis in patients with com-
promised immune responsiveness may be impli-
cated. Increased free DNA and anti-DNA antibody
levels [20, 21] and complement-mediated leuko-
penia have been shown to occur in patients on dial-
ysis [22]. Both transfusions and contact of circulat-
ing blood with foreign surfaces (with alteration of
proteins to become autoimmunogenic) might favor
CIC formation.
Transient disappearance of CIC's has been found
in some patients immediately after transplantation.
This was not accompanied by detectable clinical
renal involvement. Possible factors are massive im-
munosuppression immediately after transplantation
and nonspecific trapping of CIC's in the newly
transplanted kidney.
Following the immediate posttransplant period,
CIC's appeared or reappeared either transiently (5/
28) or in a more persistent form (15/28). In the tran-
sient appearances, a causative association was sug-
gested in 3/5 of them. In those patients with per-
sistent dC, an accountable cause for their appear-
ance or reappearance was seen in only 6/15 (3
rejections, 2 infection, 1 breast cancer), but 12
(86%) of these with posttransplant CIC's also had
them before transplantation. In contrast, only in 2
of 12 patients (17%) without preformed CIC did
they appear subsequently, and in both patients
there were accountable causes. The incidence of
episodes of infections and rejections was similar in
the two groups, suggesting that the pretransplanta-
tion CIC status was the most important determinant
for subsequent posttransplant CIC appearances.
Persistent mixed cryoglobulinemia after trans-
plantation has also been found frequently in those
who had them before [11].
A close relationship between acute rejections and
CIC's was reported by Ooi et al [8] and Vincent, Re-
villard, and Traeger [23], whereas the association
was much less striking in other series [9, 10]. Ooi et
al [8] also noted that CIC's were detectable only with
humorally mediated rejections characterized by fi-
brin deposition in glomeruli and/or arteries and not
in patients with cell-mediated rejections. In 19 epi-
sodes of acute graft rejections that we have serially
studied with donor-specific LMC assays, 12 (63%)
became positive at the time of rejection, indicating
cellular type rejection. CIC's were also present in 8
of these LMC-positive rejection episodes, but, un-
like LMC, had become positive or reappeared (if
previously positive) in close association with rejec-
tion in only three. On three occasions, CIC's were
present in LMC-D-negative rejections, but their ap-
pearance or reappearance was closely associated
with rejection in only one of the three; a humoral
rejection cannot be ruled out in these LMC-D-nega-
tive rejections but was not detectable by cytotoxic
antibodies to donor T or B cells, when the latter
were available for testing.
Intercurrent infections especially when persistent
might lead to formation of CIC's in immuno-
depressed states. Transient mixed cryoglobuli-
nemia associated with infections in renal transplant
recipients has been reported in 9/10 instances [11].
We have seen transient presence of CIC in 2 pa-
tients having infections and protracted presence of
CIC in one with CMV infection and another with
wound infection. The overall incidence of CIC asso-
ciated with infections was, however, only 27% in
this study. Hepatitis B antigenemia was not detect-
ed in any of our patients.
CIC's have been detected transiently (2 patients)
and for prolonged periods (7 patients) in patients
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studied during apparent immunologic quiescence.
Other workers have also made similar observations
[10, 19] in contrast to the findings of Ooi et al [8]. In
summary, our observations suggest that CIC's de-
tected after renal transplantation are multifactorial
in origin. The presence of pretransplant CIC's is the
most important single factor. Acute graft rejections
and intercurrent infections may have been respon-
sible for appearance of CIC' s in a minority of in-
stances.
The lower frequency of CIC's (18%) in long-sur-
viving grafts compared with those studied in the
first year after the transplantation period (68%) sug-
gests that, in most patients, CIC's disappear slowly
and spontaneously after transplantation without
any demonstrable renal injury. Why this occurs is
not clear, but possible factors are absence of hemo-
dialysis and reduced immune responsiveness. An-
other possibility is that the clearance of CIC's by
the reticuloendothelial system may have been sup-
pressed during earlier periods of maximal CIC for-
mation (from whatever cause). Later, a reduced
CIC formation may also be associated with a gradu-
al increase in reticuloendothelial clearance as that
function also returns to normal. Our current re-
search is examining this hypothesis.
The present study also did not warrant any con-
clusion on the possible beneficial role for CIC's in
transplantation. It has been suggested that 1gM anti-
bodies to gamma globulins (rheumatoid factor),
seen in about 2/3 patients after transplantation, may
possibly interfere with complement-mediated cyto-
toxicity and "protect" the graft [24].
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